NCT05417906 Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05404763 Mepolizumab and Physical Activity in Severe Asthma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05398263 Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma Status TERMINATED Phase PHASE3
NCT05397834 A Bioequivalence Study Between Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 250 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions Status UNKNOWN Phase PHASE1
NCT05366764 First-in-human Study of SAR443765 in Healthy Participants and in Asthmatic Participants Status COMPLETED Phase PHASE1
NCT05366309 Performance and Adherence in Children Using Spacers Status ACTIVE_NOT_RECRUITING Phase NA
NCT05364957 Intragastric Balloon in Obese Patients With Uncontrolled Asthma Status RECRUITING Phase NA
NCT05364632 Aerobic Training Versus Behavioral Intervention to Increase Physical Activity in Patients With Asthma Status RECRUITING Phase NA
NCT05363670 Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma Status COMPLETED Phase PHASE2
NCT05347771 Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05345080 Houston "Breathe Easy" Healthy Homes-Based Model for Multifamily Rental Communities Status UNKNOWN Phase NA
NCT05341726 BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma Status RECRUITING Phase NA
NCT05332834 A Phase 1 Study of Single and Multiple Intravenous Doses of SM17 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05330637 Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China. Status UNKNOWN Phase N/A
NCT05329194 Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States Status COMPLETED Phase PHASE4
NCT05322707 BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient Status COMPLETED Phase PHASE3